Emanuele Zucca

42.7k total citations · 5 hit papers
404 papers, 21.0k citations indexed

About

Emanuele Zucca is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Emanuele Zucca has authored 404 papers receiving a total of 21.0k indexed citations (citations by other indexed papers that have themselves been cited), including 325 papers in Pathology and Forensic Medicine, 165 papers in Oncology and 142 papers in Genetics. Recurrent topics in Emanuele Zucca's work include Lymphoma Diagnosis and Treatment (321 papers), Chronic Lymphocytic Leukemia Research (124 papers) and Viral-associated cancers and disorders (95 papers). Emanuele Zucca is often cited by papers focused on Lymphoma Diagnosis and Treatment (321 papers), Chronic Lymphocytic Leukemia Research (124 papers) and Viral-associated cancers and disorders (95 papers). Emanuele Zucca collaborates with scholars based in Switzerland, Italy and United Kingdom. Emanuele Zucca's co-authors include Franco Cavalli, Francesco Bertoni, Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington, Lawrence H. Schwartz, Tim Lister, Enrico Roggero, Andrés J.M. Ferreri and Martin Dreyling and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Emanuele Zucca

391 papers receiving 20.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

2014 3.2k citations Bruce D. Cheson, Richard I. Fisher et al. Journal of Clinical Oncology profile →
Revised Response Criteria for Malignant Lymphoma

2007 3.2k citations Bruce D. Cheson, Bertrand Coiffier et al. Journal of Clinical Oncology profile →
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

2014 989 citations Sally F. Barrington, N. George Mikhaeel et al. Journal of Clinical Oncology profile →
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

2005 582 citations Andrés J.M. Ferreri, Emanuele Zucca et al. Journal of Clinical Oncology profile →
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

2016 328 citations Anastasios Stathis, Franck Morschhauser et al. profile →

Peers

Countries citing papers authored by Emanuele Zucca

Since Specialization

Citations

This map shows the geographic impact of Emanuele Zucca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuele Zucca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuele Zucca more than expected).

Fields of papers citing papers by Emanuele Zucca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuele Zucca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuele Zucca. The network helps show where Emanuele Zucca may publish in the future.

Co-authorship network of co-authors of Emanuele Zucca

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuele Zucca. A scholar is included among the top collaborators of Emanuele Zucca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuele Zucca. Emanuele Zucca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting CD25 + lymphoma cells with the antibody–drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents 2024 ·British Journal of Haematology ·Filippo Spriano, Chiara Tarantelli, (unknown), Eugenio Gaudio, Gaetanina Golino, Lorenzo Scalise, Maria Teresa Cacciapuoti, Emanuele Zucca, Anastasios Stathis, Patrick H. van Berkel, Giorgio Inghirami, Francesca Zammarchi, Francesco Bertoni	2
2	PET-Based Prognostic Stratification in Primary Mediastinal B-Cell Lymphoma Using the SUV≥4 Segmentation Threshold: A Comparative Analysis of Contouring Methods in the IELSG37 Trial Cohort 2024 ·Blood ·Luca Ceriani, Lisa Milan, Maria Cristina Pirosa, Alice Di Rocco, (unknown), Luciano Cascione, Peter Johnson, Andrew Davies, Maurizio Martelli, Emanuele Zucca	1
3	Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma 2024 ·Human Vaccines & Immunotherapeutics ·Maria Cristina Pirosa, Anastasios Stathis, Emanuele Zucca	5
4	The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib 2023 ·British Journal of Haematology ·Giulio Sartori, Chiara Tarantelli, Filippo Spriano, Eugenio Gaudio, Luciano Cascione, (unknown), Marilia Barreca, Alberto J. Arribas, (unknown), Gaetanina Golino, (unknown), Stefano Pileri, Giovanna Damia, Emanuele Zucca, Anastasios Stathis, Oliver Politz, Antje M. Wengner, Francesco Bertoni	7
5	Revised MALT‐IPI: A new predictive model that identifies high‐risk patients with extranodal marginal zone lymphoma 2022 ·American Journal of Hematology ·Juan Pablo Alderuccio, Isildinha M. Reis, Thomas M. Habermann, Brian K. Link, Catherine Thiéblemont, Annarita Conconi, Melissa C. Larson, Luciano Cascione, Wei Zhao, James R. Cerhan, Emanuele Zucca, Izidore S. Lossos	12
6	D _max : A simple and reliable PET/CT‐derived new biomarker of lymphoma outcome? 2022 ·Hematological Oncology ·Luca Ceriani, Emanuele Zucca	4
7	Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors 2021 ·Blood Advances ·Afua A. Mensah, Filippo Spriano, Giulio Sartori, (unknown), Luciano Cascione, Eugenio Gaudio, Chiara Tarantelli, (unknown), Luca Aresu, Andrea Rinaldi, Giovanna Damia, Emanuela Lovati, Emanuele Zucca, Anastasios Stathis, Claudio Pietra, Francesco Bertoni	12
8	Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial 2020 ·Hematological Oncology ·Emanuele Zucca, Luciano Cascione, (unknown), (unknown), Sämi Schär, Stefanie Hayoz, Stefan Dirnhofer, Luca Giovanella, Mario Bargetzi, Christoph Mamot, Luca Ceriani	16
9	Prognostic models for primary mediastinal (thymic) B‐cell lymphoma derived from 18‐FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study 2017 ·British Journal of Haematology ·Luca Ceriani, Maurizio Martelli, Annarita Conconi, Pier Luigi Zinzani, Andrés J.M. Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Luca Giovanella, Emanuele Zucca, Peter Johnson	23
10	Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628 2016 ·Cancer Discovery ·Anastasios Stathis, Emanuele Zucca, Mohamed Békradda, Carlos Gomez‐Roca, Jean‐Pierre Delord, Thibault De La Motte Rouge, Emmanuelle Uro‐Coste, Filippo de Braud, Giuseppe Pelosi, Christopher A. French	268
11	Limited Benefit of Additional Contrast-Enhanced CT to End-of- Treatment PET-CT Evaluation in Patients with Follicular Lymphoma 2016 ·Blood ·Gaetano Paone, (unknown), Anastasios Stathis, Luca Giovanella, Emanuele Zucca, Luca Ceriani	1
12	The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs 2015 ·Clinical Cancer Research ·Michela Boi, Eugenio Gaudio, Paola Bonetti, Ivo Kwee, Elena Bernasconi, Chiara Tarantelli, Andrea Rinaldi, Monica Testoni, Luciano Cascione, Maurilio Ponzoni, Afua A. Mensah, Anastasios Stathis, Georg Stüssi, María E. Riveiro, Patrice Herait, Giorgio Inghirami, Esteban Cvitkovic, Emanuele Zucca, Francesco Bertoni	214
13	[ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study 2014 ·Journal of Clinical Oncology ·Maurizio Martelli, Luca Ceriani, Emanuele Zucca, Pier Luigi Zinzani, Andrés J.M. Ferreri, Umberto Vitolo, Caterina Stelitano, Ercole Brusamolino, Maria Giuseppina Cabras, Luigi Rigacci, Monica Balzarotti, Flavia Salvi, Silvia Montoto, Armando López‐Guillermo, Erica Finolezzi, Stefano Pileri, Andrew Davies, Franco Cavalli, Luca Giovanella, Peter Johnson	106
14	Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group breakdown → 2014 ·Journal of Clinical Oncology ·Sally F. Barrington, N. George Mikhaeel, Lale Kostakoğlu, Michel Meignan, Martin Hutchings, Stefan Müeller, Lawrence H. Schwartz, Emanuele Zucca, Richard I. Fisher, Judith Trotman, Otto S. Hoekstra, Rodney J. Hicks, Michael O’Doherty, Roland Hustinx, Alberto Biggi, Bruce D. Cheson	989
15	Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study 2013 ·Journal of Clinical Oncology ·Emanuele Zucca, Annarita Conconi, Daniele Laszlò, Armando López‐Guillermo, Réda Bouabdallah, Bertrand Coiffier, Catherine Sebban, Fabrice Jardin, Umberto Vitolo, Franck Morschhauser, Stefano Pileri, Christiane Copie‐Bergman, Elı́as Campo, Andrew Jack, Irene Floriani, Peter Johnson, Maurizio Martelli, Franco Cavalli, Giovanni Martinelli, Catherine Thiéblemont	148
16	Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial 2012 ·Journal of Clinical Oncology ·Andrés J.M. Ferreri, Silvia Govi, Elisa Pasini, Silvia Mappa, Francesco Bertoni, Francesco Zaja, Carlos Montalbán, Caterina Stelitano, María Elena Cabrera, Antonio Giordano Resti, Letterio S. Politi, Claudio Doglioni, Franco Cavalli, Emanuele Zucca, Maurilio Ponzoni, Riccardo Dolcetti	117
17	Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98 2010 ·Journal of Clinical Oncology ·Giovanni Martinelli, Shu-Fang Hsu Schmitz, (unknown), Thomas Cerny, U Hess, Simona Bassi, (unknown), Roger Stupp, Rolf A. Stahel, Marc Heizmann, Daniel Vorobiof, Andreas Lohri, Pierre-Yves Dietrich, Emanuele Zucca, Michele Ghielmini	168
18	The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas 2009 ·Blood ·Urban Novak, Andrea Rinaldi, Ivo Kwee, Subhadra V. Nandula, Paola M. V. Rancoita, Mara Compagno, Michaela Cerri, Davide Rossi, Vundavalli V. Murty, Emanuele Zucca, Gianluca Gaïdano, Riccardo Dalla‐Favera, Laura Pasqualucci, Govind Bhagat, Francesco Bertoni	184
19	Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B‐cell lymphomas 2009 ·Hematological Oncology ·Marta Scandurra, Davide Rossi, Clara Deambrogi, Paola M. V. Rancoita, Ekaterina Chigrinova, Michael Mian, Michaela Cerri, Silvia Rasi, Elisa Sozzi, Francesco Forconi, Maurilio Ponzoni, Santiago Montes‐Moreno, Miguel Á. Piris, Giorgio Inghirami, Emanuele Zucca, Valter Gattei, Andrea Rinaldi, Ivo Kwee, Gianluca Gaïdano, Francesco Bertoni	37
20	Distribution of Mobilized Progenitor Cells in the Buffy Coat of the Haemonetics MCS3p Cell Separator: A Study to Optimize the Collection of Progenitors by Leukapheresis 1998 ·Journal of Hematotherapy ·Michele Ghielmini, Ulrich Pfister, Emanuele Zucca, (unknown), (unknown), (unknown), Gloria Bertoli, (unknown), F. Cavalli	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact